Clinical management of patients with the long QT syndrome: Drugs, devices, and gene-specific therapy

PACE - Pacing and Clinical Electrophysiology

Volumn 20, Issue 8 II, 1997, Pages 2058-2060

  Moss, Arthur J ^a,b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Gene specific therapy; Long QT syndrome; Sudden death; Sympathetic nervous system

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; MEXILETINE; POTASSIUM; SPIRONOLACTONE;

CONFERENCE PAPER; DEFIBRILLATOR; GANGLIONECTOMY; HEART PACING; HUMAN; LONG QT SYNDROME; ORAL DRUG ADMINISTRATION; STELLATE GANGLION;

ADRENERGIC BETA-ANTAGONISTS; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; GANGLIONECTOMY; GENE THERAPY; GENOTYPE; HUMANS; ION CHANNELS; LONG QT SYNDROME; MUTATION; PACEMAKER, ARTIFICIAL; PHENOTYPE; POTASSIUM CHANNELS; SODIUM CHANNELS; SYNCOPE, VASOVAGAL; TACHYCARDIA, VENTRICULAR;

EID: 0030786548     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1997.tb03627.x     Document Type: Article

References (20)

1. Moss AJ, Schwartz PJ, Crampton RS, et al. The long QT syndrome: Prospective longitudinal study of 328 families. Circulation 1991; 84:1136-1144.
2. Vincent GM, Timothy KW, Leppert M, et al. The spectrum of symptoms and QT intervals in carriers of the gene for the long QT syndrome. N Engl J Med 1992; 327:846-852.
3. Keating M, Atkinson D, Dunn C, et al. Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene. Science 1991; 252:704-706.
4. Jiang C, Atkinson D, Towbin JA, et al. Two long QT syndrome loci map to chromosomes 3 and 7 with evidence for further heterogeneity. Nat Genet 1994; 8:141-147.
5. Wang Q, Shen J, Splawski I, et al. SCN5A mutations cause an inherited cardiac arrhythmia, long QT syndrome. Cell 1995; 80:805-811.
6. Curran ME, Splawski I, Timothy K, et al. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995; 80:795-803.
7. Wang W, Curran ME, Splawski I, et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 1996; 12:17-23.
8. Moss AJ, Zareba W, Benhorin J, et al. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation 1995; 92: 2929-2934.
9. Ks cardiac potassium current. Nature 1996; 384: 78-80.
10. Ks potassium channel. Nature 1996; 384:80-83.
11. Kiehn J, Lacerda AE, Wible B, et al. Molecular physiology and pharmacology of HERG: Single channel currents and block by dofetilide. Circulation 1996; 94:2572-2579.
12. + channel-linked long-QT syndrome. Circulation 1996; 78:916-924.
13. Moss AJ, Robinson J. Clinical features of idiopathic long QT syndrome. Circulation 1992; 85(Suppl. I):I-140-144.
14. + channel blockade and to increases in heart rate: Implications for gene-specific therapy. Circulation 1995; 92:3381-3386.
15. Compton SJ, Lux RL, Ramsey MR, et al. Genetically defined therapy of inherited long-QT syndrome: Correction of abnormal repolarization by potassium. Circulation 1996; 94:1018-1022.
16. Eldar M, Griffin JC, Abbott JA, et al. Permanent cardiac pacing in patients with the long QT syndrome. J Am Coll Cardiol 1987; 10:600-607.
17. Moss AJ, Liu JE, Gottlieb S, et al. Efficacy of permanents pacing in the management of high risk patients with long QT syndrome. Circulation 1991; 84:1524-1529.
18. Bhandari AK, Scheinman MM, Morady F, et al. Efficacy of left cardiac sympathcctomy in the treatment of patients with the long QT syndrome. Circulation 1984; 70:1018-1023.
19. Schwartz PJ, Locati E, Moss AJ, et al. Left cardiac sympathetic denervation in the therapy of the congenital long QT syndrome: A worldwide report. Circulation 1991; 84:503-511.
20. Ouriel K, Moss AJ. Long QT syndrome: An indication for cervicothoracic sympathectomy. Card Surg 1995; 3:475-478.